CD103+CD11b+ DC2 populations were reported in the gut in various models [26, 27], but whether the CD103loCD11b+ DCs we observed following cancer development were functionally similar to gut CD103+ DC2s remained unclear. This evidence concerns the gene ITGAM and cancer.